Drug Shortage Report for AURO-AZITHROMYCIN

Last updated on 2024-02-14 History
Report ID 163395
Drug Identification Number 02482363
Brand name AURO-AZITHROMYCIN
Common or Proper name AZITHROMYCIN
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 15ml
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-23
Estimated end date 2022-12-30
Actual end date 2023-01-30
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-06-23 English Compare
v2 2022-06-23 French Compare
v3 2022-06-24 English Compare
v4 2022-07-04 English Compare
v5 2022-07-04 French Compare
v6 2022-07-04 English Compare
v7 2022-07-04 French Compare
v8 2022-07-04 English Compare
v9 2022-07-04 French Compare
v10 2022-07-04 English Compare
v11 2022-07-04 French Compare
v12 2022-12-08 English Compare
v13 2022-12-30 English Compare
v14 2022-12-30 French Compare
v15 2023-01-31 English Compare
v16 2024-02-14 English Compare

Showing 1 to 16 of 16